BioCardia, Inc.
BCDA
$2.23
-$0.02-0.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 198.27% | -267.24% | |||
| Gross Profit | -198.27% | 267.24% | |||
| SG&A Expenses | 32.01% | 9.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.45% | 32.18% | |||
| Operating Income | -17.45% | -32.18% | |||
| Income Before Tax | -18.12% | -32.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.12% | -32.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.12% | -32.18% | |||
| EBIT | -17.45% | -32.18% | |||
| EBITDA | -17.69% | -32.53% | |||
| EPS Basic | -16.88% | 18.53% | |||
| Normalized Basic EPS | -16.88% | 18.54% | |||
| EPS Diluted | 41.70% | -63.34% | |||
| Normalized Diluted EPS | -16.88% | 18.54% | |||
| Average Basic Shares Outstanding | 1.05% | 62.25% | |||
| Average Diluted Shares Outstanding | 1.05% | 62.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||